HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomoo Kosuge Selected Research

Pancreatic Ductal Carcinoma

7/2013Gemcitabine in patients with intraductal papillary mucinous neoplasm with an associated invasive carcinoma of the pancreas.
9/2012Assessment of the interface between retroperitoneal fat infiltration of pancreatic ductal carcinoma and the major artery by multidetector-row computed tomography: surgical outcomes and correlation with histopathological extension.
4/2011Intrapancreatic nerve invasion as a predictor for recurrence after pancreaticoduodenectomy in patients with invasive ductal carcinoma of the pancreas.
2/2008Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms.
10/2006Reappraisal of the clinical significance of tumor size in patients with pancreatic ductal carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomoo Kosuge Research Topics

Disease

45Neoplasms (Cancer)
12/2016 - 08/2002
28Pancreatic Neoplasms (Pancreatic Cancer)
02/2019 - 03/2004
22Neoplasm Metastasis (Metastasis)
02/2019 - 08/2002
18Hepatocellular Carcinoma (Hepatoma)
12/2014 - 01/2002
10Adenocarcinoma
06/2016 - 08/2002
7Cholangiocarcinoma
09/2015 - 08/2007
7Lymphatic Metastasis
11/2009 - 10/2006
5Carcinogenesis
04/2014 - 07/2005
5Pancreatic Ductal Carcinoma
07/2013 - 10/2006
5Carcinoma (Carcinomatosis)
07/2013 - 12/2006
5Margins of Excision
01/2012 - 08/2007
4Pancreatic Fistula (Pancreatic Fistulas)
09/2017 - 11/2005
4Neoplasms, Cystic, Mucinous, and Serous
01/2016 - 09/2006
4Bile Duct Neoplasms (Bile Duct Cancer)
06/2013 - 07/2003
4Colorectal Neoplasms (Colorectal Cancer)
10/2011 - 12/2006
3Gallbladder Neoplasms (Gallbladder Cancer)
12/2015 - 06/2013
3Klatskin Tumor
01/2015 - 06/2005
3Infections
08/2010 - 04/2007
2Liver Cirrhosis (Hepatic Cirrhosis)
07/2019 - 08/2007
2Surgical Wound Infection
12/2017 - 09/2017
2Biliary Tract Neoplasms (Biliary Tract Cancer)
06/2016 - 09/2015
2Cholangitis
06/2016 - 08/2006
2Stomach Neoplasms (Stomach Cancer)
04/2014 - 06/2007
2Colonic Neoplasms (Colon Cancer)
03/2010 - 01/2008
2Thrombosis (Thrombus)
11/2009 - 07/2008
2Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
12/2008 - 11/2006
2Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
07/2008 - 06/2005
2Pathologic Constriction (Stenosis)
01/2008 - 07/2005
1Portal Hypertension
07/2019
1Ascites
07/2019
1Residual Neoplasm
02/2019
1Wounds and Injuries (Trauma)
09/2017
1Necrosis
12/2016
1Papillary Adenocarcinoma
01/2014

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
01/2016 - 07/2005
10Biomarkers (Surrogate Marker)IBA
05/2017 - 11/2005
7GemcitabineFDA Link
02/2019 - 04/2004
7Biological ProductsIBA
12/2016 - 04/2005
5AntigensIBA
02/2012 - 05/2006
4ProteomeIBA
02/2012 - 11/2005
4CarbohydratesIBA
02/2012 - 02/2008
3EnzymesIBA
11/2015 - 07/2005
3Blood Proteins (Serum Proteins)IBA
01/2012 - 11/2005
2Prothrombin (Factor II)IBA
07/2019 - 11/2011
2AntibodiesIBA
11/2015 - 09/2006
2Apolipoprotein A-II (Apolipoprotein A2)IBA
11/2015 - 01/2012
2Carcinoembryonic AntigenIBA
10/2014 - 03/2007
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2014 - 01/2007
2Indicators and Reagents (Reagents)IBA
01/2013 - 08/2006
2Peptides (Polypeptides)IBA
03/2011 - 01/2011
2CXC ChemokinesIBA
01/2011 - 01/2007
2DNA (Deoxyribonucleic Acid)IBA
12/2009 - 07/2005
2alpha-Fetoproteins (alpha-Fetoprotein)IBA
11/2009 - 06/2003
2Small Interfering RNA (siRNA)IBA
04/2009 - 09/2008
2Imatinib Mesylate (Gleevec)FDA Link
07/2008 - 06/2005
2beta CateninIBA
11/2007 - 11/2006
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
08/2007 - 11/2005
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
07/2019
1Tumor Biomarkers (Tumor Markers)IBA
02/2019
1SilkFDA Link
09/2017
1perfluoro- 2,2,2',2'- tetramethyl- 4,4'- bis(1,3- dioxolane)IBA
06/2016
1Insulin-Like Growth Factor Binding ProteinsIBA
01/2016
1Insulin-Like Growth Factor Binding Protein 2IBA
01/2016
1Oncogene Protein v-cblIBA
12/2015
1ImmunosorbentsIBA
11/2015
1Protein Isoforms (Isoforms)IBA
11/2015
1Immune Checkpoint ProteinsIBA
09/2015
1Complement System Proteins (Complement)IBA
12/2014
1Epithelial Cell Adhesion MoleculeIBA
10/2014
1Mucin-1 (CA 15-3 Antigen)IBA
10/2014
1Angiopoietin-2IBA
10/2014
1Keratin-7 (Cytokeratin 7)IBA
10/2014
1Hematoxylin (Haematoxylon)IBA
06/2014
1Eosine Yellowish-(YS) (Eosin)IBA
06/2014
1victoria blueIBA
06/2014
1Phosphotransferases (Kinase)IBA
04/2014
1Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
04/2014
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
04/2014
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
04/2014
1CarcinogensIBA
03/2014
1MicroRNAs (MicroRNA)IBA
05/2013
1Carbonic Anhydrase IXIBA
01/2013

Therapy/Procedure

27Hepatectomy
09/2017 - 01/2002
14Pancreaticoduodenectomy
07/2019 - 07/2005
10Therapeutics
12/2014 - 03/2006
10Pancreatectomy
07/2012 - 03/2006
7Drug Therapy (Chemotherapy)
12/2014 - 04/2004
4Adjuvant Chemotherapy
12/2016 - 01/2008
4Operative Surgical Procedures
06/2013 - 07/2008
3Neoadjuvant Therapy
02/2019 - 10/2006
3Contraindications
12/2014 - 03/2004
3Blood Transfusion (Blood Transfusions)
02/2010 - 04/2007
3Lymph Node Excision (Lymph Node Dissection)
04/2009 - 03/2006
2Sutures (Suture)
12/2017 - 09/2017
2Lasers (Laser)
01/2012 - 11/2005
2Thrombectomy
11/2009 - 01/2007
1Length of Stay
09/2017
1Catheters
06/2016
1Molecular Targeted Therapy
09/2015
1Liver Transplantation
12/2014